Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021

Author:

Corrao Giovanni,Biffi Annalisa,Porcu Gloria,Ronco Raffaella,Adami Giovanni,Alvaro Rosaria,Bogini Riccardo,Caputi Achille Patrizio,Cianferotti Luisella,Frediani Bruno,Gatti Davide,Gonnelli Stefano,Iolascon Giovanni,Lenzi Andrea,Leone Salvatore,Michieli Raffaella,Migliaccio Silvia,Nicoletti Tiziana,Paoletta Marco,Pennini Annalisa,Piccirilli Eleonora,Rossini Maurizio,Tarantino Umberto,Brandi Maria Luisa

Abstract

BackgroundFragility fractures are a major public health concern owing to their worrying and growing burden and their onerous burden upon health systems. There is now a substantial body of evidence that individuals who have already suffered a fragility fracture are at a greater risk for further fractures, thus suggesting the potential for secondary prevention in this field.PurposeThis guideline aims to provide evidence-based recommendations for recognizing, stratifying the risk, treating, and managing patients with fragility fracture. This is a summary version of the full Italian guideline.MethodsThe Italian Fragility Fracture Team appointed by the Italian National Health Institute was employed from January 2020 to February 2021 to (i) identify previously published systematic reviews and guidelines on the field, (ii) formulate relevant clinical questions, (iii) systematically review literature and summarize evidence, (iv) draft the Evidence to Decision Framework, and (v) formulate recommendations.ResultsOverall, 351 original papers were included in our systematic review to answer six clinical questions. Recommendations were categorized into issues concerning (i) frailty recognition as the cause of bone fracture, (ii) (re)fracture risk assessment, for prioritizing interventions, and (iii) treatment and management of patients experiencing fragility fractures. Six recommendations were overall developed, of which one, four, and one were of high, moderate, and low quality, respectively.ConclusionsThe current guidelines provide guidance to support individualized management of patients experiencing non-traumatic bone fracture to benefit from secondary prevention of (re)fracture. Although our recommendations are based on the best available evidence, questionable quality evidence is still available for some relevant clinical questions, so future research has the potential to reduce uncertainty about the effects of intervention and the reasons for doing so at a reasonable cost.

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference399 articles.

1. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures;Davis;Health Technol Assess,2016

2. GenevaAssessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series, no. 8431994

3. Hip fractures in the elderly: a world-wide projection;Cooper;Osteoporos Int,1992

4. Broken bones, broken lives – the fragility fracture crisis in six European countries2018

5. Glossary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3